Another likely benefit of anti-apoE4 therapy is a reduction in the associated morbidities, e.g., cardiovascular disease, particularly coronary artery disease and impaired repair following head trauma, which are more common among APOE4 carriers [236]. The gene discussed is APOE; the disease is coronary artery disorder.